Crispr Therapeutics Stock Quote 0VRQ - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

64.60

Bid

0.00

Ask

0.00

Volume

2,178

0.00 Day's Range 0.00

64.60 52 Week Range 64.60

Market Cap

5.16B

Previous Close

64.60

Open

Last Trade

40.875

(O)

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

4,581

Shares Outstanding

79,874,000

Dividend Yield

PE Ratio

-21.29

Earnings Per Share (EPS)

-1.92

Revenue

371.21M

Net Profit

-153.61M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.crisprtx.com

Headquarters

Zug, Che

Founded

Crispr Therapeutics Ag is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0VRQ. The last closing price for Crispr Therapeutics was $64.60. Over the last year, Crispr Therapeutics shares have traded in a share price range of $ 64.60 to $ 64.60.

Crispr Therapeutics currently has 79,874,000 shares outstanding. The market capitalization of Crispr Therapeutics is $5.16 billion. Crispr Therapeutics has a price to earnings ratio (PE ratio) of -21.29.

No news to show yet.

Period	Open	High	Low	Avg. Daily Vol	VWAP
1	64.6	64.6	64.6	9252	64.6	DE
4	64.6	64.6	64.6	5801	64.6	DE
12	64.6	64.6	64.6	4581	64.6	DE
26	64.6	64.6	64.6	3729	64.6	DE
52	64.6	64.6	64.6	4291	64.6	DE
156	64.6	64.6	64.6	2615	64.6	DE
260	64.6	64.6	64.6	1834	64.6	DE

0VRQ - Frequently Asked Questions (FAQ)

What is the current Crispr Therapeutics share price?

The current share price of Crispr Therapeutics is $ 64.60

How many Crispr Therapeutics shares are in issue?

Crispr Therapeutics has 79,874,000 shares in issue

What is the market cap of Crispr Therapeutics?

The market capitalisation of Crispr Therapeutics is USD 5.16B

What is the 1 year trading range for Crispr Therapeutics share price?

Crispr Therapeutics has traded in the range of $ 64.60 to $ 64.60 during the past year

What is the PE ratio of Crispr Therapeutics?

The price to earnings ratio of Crispr Therapeutics is -21.29

What is the cash to sales ratio of Crispr Therapeutics?

The cash to sales ratio of Crispr Therapeutics is 8.81

What is the reporting currency for Crispr Therapeutics?

Crispr Therapeutics reports financial results in USD

What is the latest annual turnover for Crispr Therapeutics?

The latest annual turnover of Crispr Therapeutics is USD 371.21M

What is the latest annual profit for Crispr Therapeutics?

The latest annual profit of Crispr Therapeutics is USD -153.61M

What is the registered address of Crispr Therapeutics?

The registered address for Crispr Therapeutics is BAARERSTRASSE 14, ZUG, 6300

What is the Crispr Therapeutics website address?

The website address for Crispr Therapeutics is www.crisprtx.com

Which industry sector does Crispr Therapeutics operate in?

Crispr Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WNWDWindward Ltd	208.00p (42.47%)	1.4M
LDGLogistics Development Group Plc	14.75p (41.83%)	2.43M
TIRTiger Royalties And Investments Plc	0.175p (16.67%)	19.85M
ASTAscent Resources Plc	2.10p (16.67%)	2.75M
LIVLivermore Investments Group Limited	54.00p (16.13%)	75.58k
AMGAtlas Metals Group Plc	11.00p (-61.40%)	1.75M
INDIIndus Gas Limited	9.00p (-25.00%)	647.82k
WEBWebis Holdings Plc	0.06p (-20.00%)	5.8M
SLFRSlf Realisation Fund Limited	1.00p (-19.03%)	279.95k
SYMESupply@me Capital Plc	0.003p (-18.92%)	42.63M
MSMNMosman Oil And Gas Limited	0.028p (-6.67%)	568.68M
NTVONativo Resources Plc	0.0019p (0.00%)	393.56M
SEESeeing Machines Limited	4.65p (0.00%)	342.73M
TRPTower Resources Plc	0.034p (-2.86%)	200.58M
PREMPremier African Minerals Limited	0.0535p (1.90%)	150.11M